M&A Deal Summary |
|
---|---|
Date | 2015-04-07 |
Target | Optimal IMX |
Sector | Medical Products |
Buyer(s) | Aris Radiology |
Sellers(s) |
Enhanced Capital Partners
Health Evolution Partners |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Aris Radiology is a provider of radiology services to hospitals nationwide.
DEAL STATS | # |
---|---|
Overall | 1 of 2 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 2 |
State (Tennessee) | 1 of 1 |
Country (United States) | 1 of 2 |
Year (2015) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-10-10 |
US Teleradiology
Atlanta, Georgia, United States US Teleradiology is a physician-owned radiology practice providing staffing and teleradiology services to hospitals, radiology groups and other medical facilities around the country. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 1999 |
PE ASSETS | 500M USD |
Size | Middle-Market |
Type | Sector Focused |
Enhanced Capital Partners is a private investment firm focused on investing in small and mid-sized growth companies generating sales up to $100 million. The Firm can invest across the capital structure, including equity and mezzanine debt financing. Enhanced also will provide funds for working capital needs. The Firm looks to invest $2 to $20 million of equity and mezzanine in the range of $500,000 to $3 million in mid to later-stage profitable companies that are seeking capital to fund growth, make an acquisition, or for an outright sale. Target sectors include aerospace, business services, communications, distribution, manufacturing, healthcare, IT, software, and retail. Enhanced Equity Partners was formed in 1999 and is based in New York City with an additional office in Austin, Birmingham, Denver, Jackson Hole, Nashville, New Orleans, Stamford, Tampa and Washington, D.C.
DEAL STATS | # |
---|---|
Overall | 21 of 26 |
Sector (Medical Products) | 1 of 2 |
Type (Add-on Acquisition) | 9 of 14 |
State (Tennessee) | 2 of 2 |
Country (United States) | 21 of 26 |
Year (2015) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-11-18 |
BinOptics
Ithaca, New York, United States BinOptics Corporation manufactures monolithically integrated optoelectronic components based on indium phosphide and other semiconductor materials. BinOptics' current products include edge-emitting and surface-emitting Fabry Perot lasers, DFB lasers, and lasers with integrated monitoring photodiodes that provide transceiver and transponder manufacturers with unprecedented price-performance advantages. Additionally, BinOptics can provide custom integrated microphotonic solutions for optical systems and subsystems. |
Sell | $230M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-08-10 |
Advanced Generation & Efficiency
New York, New York, United States Advanced Generation & Efficiency finances and manages the installation, operations, and maintenance of renewable energy technologies and energy efficient equipment for existing buildings. |
Buy | - |
Health Evolution Partners was a private investment firm focused on investing in rapidly growing healthcare companies. The Firm targeted opportunities across all sectors of the healthcare industry including hospitals, physicians, managed care, pharmaceutical developers, device makers, and consumer products/services. Health Evolution Partners was established in 2007 and was headquartered in San Francisco, California.
DEAL STATS | # |
---|---|
Overall | 1 of 4 |
Sector (Medical Products) | 1 of 2 |
Type (Add-on Acquisition) | 1 of 2 |
State (Tennessee) | 1 of 1 |
Country (United States) | 1 of 3 |
Year (2015) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2012-02-28 |
Freedom Innovations
Irvine, California, United States Freedom Innovations designs and manufactures advanced technology lower-limb prosthetic devices geared towards amputees with active lifestyles. The Company manufactures its products using 100% carbon-fiber composite materials, maximizing strength and energy return while minimizing weight. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-01-01 |
Prolacta Bioscience
Adelaide, Australia Prolacta Bioscience is a biopharmaceutical company developing and marketing human milk-based nutritional products for premature infants in the neonatal intensive care unit. Prolacta Bioscience was founded in 1999 and is based in Adelaide, Australia. |
Buy | - |